FULLHOPE BIOMEDICAL CO LTD has a total of 22 patent applications. Its first patent ever was published in 2012. It filed its patents most often in Taiwan, United States and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are VESTA THERAPEUTICS INC, POLYBIOCEPT GMBH and VALNEVA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Taiwan | 7 | |
#2 | United States | 7 | |
#3 | China | 6 | |
#4 | Canada | 1 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Lee Jan-Mou | 12 |
#2 | Lee Jan Mou | 9 |
#3 | Jhou Kai-Yuan | 2 |
#4 | Wei Da-Tsen | 2 |
#5 | Fang Chih-Hao | 2 |
#6 | Cheng Ya-Fang | 2 |
#7 | Wei Da Tsen | 1 |
#8 | Tsai Yih-Jin | 1 |
#9 | Cheng Ya Fang | 1 |
#10 | Jhou Kai Yuan | 1 |
Publication | Filing date | Title |
---|---|---|
TW201710497A | Modified natural killer t cells, pharmaceutical compositions and uses thereof | |
US2016045548A1 | Method for treating cancers with dendritic killer cells and pharmaceutical composition comprising the same | |
US2016074490A1 | Formulation and method for preparing specific T cell, and method for preparing the formulation | |
TW201402814A | A formulation and method for preparing specific t cell, and a preparation method of the formulation | |
TW201403067A | A method for identifying and screening cytotoxic dendritic cells | |
TW201402816A | Formulation and method for cultivating cytotoxic dendritic cells | |
TW201402137A | Application of cytotoxic dendritic cells for manufacturing medication and comprising pharmaceutical composition | |
TW201403110A | Detection system for underground pollution mass and method for the same |